Testing effectiveness (Phase 2)WithdrawnNCT00814593
What this trial is testing
Lymphokine-Activated Killer Cells or Gliadel Wafer in Treating Patients With Newly Diagnosed Glioblastoma Multiforme That Can Be Removed by Surgery
Who this might be right for
Brain and Central Nervous System Tumors
Lisata Therapeutics, Inc.